BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  BrightGene Announces Positive Topline Phase 1 Results of Oral BGM0504 in Obesity in China and the United States

  March 25, 2026

   · 

  3 min read
• Press Releases

  Philips launches IntraSight Plus to simplify coronary interventions and advance precision care

  March 25, 2026

   · 

  5 min read
• 

  Funding

  RA Capital Looks to China for Next Startup To Put on SPAC Track to Nasdaq

  While RA Capital Management has yet to commit to a merger plan, it noted that its new blank-check company, Research Alliance III, could target companies abroad, including those from China.

  March 25, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Cancer

  Karyopharm Slides as Mixed Myelofibrosis Results Cloud Regulatory Road

  Missing one of its co-primary endpoints could make it difficult for Karyopharm Therapeutics to score conventional approval for Xpovio in myelofibrosis, according to Jefferies analysts.

  March 25, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  ADMA Biologics Addresses Misleading Short-Seller Report

  March 25, 2026

   · 

  2 min read
• Press Releases

  Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

  March 25, 2026

   · 

  13 min read
• Press Releases

  Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite

  March 25, 2026

   · 

  3 min read
• Press Releases

  Cellbricks Therapeutics Raises €10 Million New Capital to Move Living Tissue Implants Toward the Clinic

  March 25, 2026

   · 

  5 min read
• Press Releases

  C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma

  March 25, 2026

   · 

  8 min read
• Press Releases

  NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset

  March 25, 2026

   · 

  8 min read